Scholarly publications and presentations by Rochester Regional Health's Allergy and Immunology department authors.
Submissions from 2021
2-1-2021 Microarray Analysis of Major Epitopes Among Tree Nut-Allergic Individuals May Explain Patterns of Cross-Desensitization, Stephen Gipson, USDA SRRC, Jacqueline Nesbit, USDA SRRC, Hsiaopo Cheng, USDA SRRC, et al.
2-2021 Safety and Tolerability of Subcutaneous IgPro20 at High Infusion Parameters in Patients with Primary Immunodeficiency: Findings from the Pump-Assisted Administration Cohorts of the HILO Study, John T. Anderson, Clinical Research Center of Alabama, Vincent R. Bonagura, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Juthaporn Cowan, University of Ottawa, et al.
1-1-2021 Five-year follow-up of early intervention peanut oral immunotherapy, Lauren Herlihy, The University of North Carolina at Chapel Hill, Edwin H. Kim, The University of North Carolina at Chapel Hill, A. Wesley Burks, The University of North Carolina at Chapel Hill, et al.
2021 Immunodeficiency Secondary to Malignancies and Biologics, S. Shahzad Mustafa, Rochester Regional Health
1-1-2021 Severity grading system for acute allergic reactions: A multidisciplinary Delphi study, Timothy E. Dribin, Cincinnati Children's Hospital Medical Center, David Schnadower, Cincinnati Children's Hospital Medical Center, Jonathan M. Spergel, University of Pennsylvania Perelman School of Medicine, et al.
Submissions from 2020
10-1-2020 Inpatient Electronic Consultations (E-consults) in Allergy/Immunology, S Shahzad Mustafa, Rochester Regional Health, Mary L. Staicu, Rochester Regional Health, Luanna Yang, Rochester Regional Health, et al.
10-1-2020 Penicillin Allergy Delabeling: A Multidisciplinary Opportunity, Mary L. Staicu, Rochester Regional Health, David Vyles, Medical College of Wisconsin, Erica S. Shenoy, Harvard Medical School, et al.
9-25-2020 Dupilumab as Add-on Therapy for Chronic Rhinosinusitis With Nasal Polyposis in Aspirin Exacerbated Respiratory Disease, S Shahzad Mustafa, Rochester Regional Health, Karthik Vadamalai, Division of Critical Care, Mercy Hospital, Springfield, Missouri., Bryan Scott, Rochester Regional Health, et al.
9-12-2020 Successful treatment of refractory eosinophilic fasciitis with reslizumab, Mahta Mortezavi, Rochester Regional Health; Mary Barrett, Rochester Regional Health; and Mohammadomid Edrissian, Department of Rheumatology, Kaiser Permanente, South Sacramento, California.
9-1-2020 Appointment characteristics in an allergy/immunology practice in the immediate aftermath of COVID-19 restrictions, Allison Ramsey, Rochester Regional Health, Luanna Yang, Rochester Regional Health, Karthik Vadamalai, Mercy Hospital, et al.
9-1-2020 Reply to “Appointment characteristics during COVID-19 restrictions: A Canadian allergy/immunology centre perspective”, Allison Ramsey, Rochester Regional Health and S Shahzad Mustafa, Rochester Regional Health
8-28-2020 Patient Characteristics and Concerns about Drug Allergy: A Report from the United States Drug Allergy Registry, Kimberly G. Blumenthal, Harvard Medical School, Boston, Mass; Division of Rheumatology, Allergy, and Immunology, Department of Medicine, Massachusetts General Hospital, Boston, Mass; Mongan Institute, Massachusetts General Hospital, Boston, Mass., Tyler Harkness, Division of Rheumatology, Allergy, and Immunology, Department of Medicine, Massachusetts General Hospital, Boston, Mass; Mongan Institute, Massachusetts General Hospital, Boston, Mass., Elizabeth J. Phillips, Division of Infectious Diseases, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tenn, et al.
7-11-2020 The Use of 20% Subcutaneous Immunoglobulin Replacement Therapy in Patients With B Cell Non-Hodgkin Lymphoma With Humoral Immune Dysfunction After Treatment With Rituximab, S Shahzad Mustafa, Rochester Regional Health, Saad Jamshed, Rochester Regional Health, Karthik Vadamalai, Division of Critical Care, Mercy Hospital, Springfield, MO., et al.
7-1-2020 Direct Challenges to Penicillin-Based Antibiotics in the Inpatient Setting, Allison Ramsey, Rochester Regional Health, S Shahzad Mustafa, Rochester Regional Health, Anne Marie Holly, Rochester Regional Health, et al.
6-26-2020 Patient satisfaction with telemedicine encounters in an allergy and immunology practice during the coronavirus disease 2019 pandemic, S Shahzad Mustafa, Rochester Regional Health, Luanna Yang, Rochester Regional Health, Mahta Mortezavi, Rochester Regional Health, et al.
6-6-2020 Penicillin Skin Testing: A Major Role for the Minor Determinant and Amoxicillin?, Allison Ramsey, Rochester Regional Health and Paul A. Greenberger, Division of Allergy and Immunology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Ill.
6-3-2020 Urticaria, Angioedema, and Anaphylaxis, Jennifer Pier, University of Rochester, Rochester, NY. and Theresa A. Bingemann, University of Rochester, Rochester, NY.
4-12-2020 Diagnostic Challenges in Anaphylaxis, Jay A. Lieberman, Department of Pediatrics, Division of Allergy and Immunology, University of Tennessee Health Science Center, LeBonheur Children's Hospital, Memphis, Tenn.; Theresa A. Bingemann, Rochester Regional Health; and Julie Wang, Department of Pediatrics, Division of Allergy and Immunology, Icahn School of Medicine at Mount Sinai, New York, NY.
4-1-2020 AAAAI Work Group Report: Physician Wellness in Allergy and Immunology, Theresa Bingemann, University of Rochester School of Medicine and Dentistry, Hemant Sharma, Childrens National Health System, Anil Nanda, Asthma and Allergy Center, et al.
4-1-2020 Big Datasets in Antibiotic Allergy: What's the Story?, Allison Ramsey, Rochester Regional Health and Mary L. Staicu, Rochester Regional Health
3-1-2020 Penicillin skin testing immunocompromised patients with systemic lupus erythematosus and rheumatoid arthritis, Mahta Mortezavi, Rochester Regional Health; S Shahzad Mustafa, Rochester Regional Health; and Allison Ramsey, Rochester Regional Health
3-1-2020 Real-world tree nut consumption in peanut-allergic individuals, S Shahzad Mustafa, Rochester Regional Health, Karthik Vadamalai, Mercy Hospital, Theresa Bingemann, Rochester Regional Health, et al.
2-1-2020 A Slice of Food Protein-Induced Enterocolitis Syndrome (FPIES): Insights from 441 Children with FPIES as Provided by Caregivers in the International FPIES Association, Michelle C. Maciag, Boston Children's Hospital, Boston, Mass; Harvard Medical School, Boston, Mass., Lisa M. Bartnikas, Boston Children's Hospital, Boston, Mass; Harvard Medical School, Boston, Mass., Scott H. Sicherer, Department of Pediatrics, Division of Allergy and Immunology, Icahn School of Medicine at Mount Sinai, New York, NY., et al.
1-1-2020 Conducting an Oral Food Challenge: An Update to the 2009 Adverse Reactions to Foods Committee Work Group Report, J. Andrew Bird, UT Southwestern Medical Center, Stephanie Leonard, University of California, San Diego, Marion Groetch, Icahn School of Medicine at Mount Sinai, et al.
1-1-2020 Efficacy of epinephrine and diphenhydramine rinses in decreasing local reactions to subcutaneous aeroallergen immunotherapy, S. Shahzad Mustafa, Rochester Regional Health, Karthik Vadamalai, Mercy Hospital, Theresa Bingemann, Rochester Regional Health, et al.